Academic Journal

1138P A prospective study of patients with immune checkpoint inhibitor-induced hepatitis: Management outcome and association with liver injury subtype, immune infiltration, and clinical parameters.

التفاصيل البيبلوغرافية
العنوان: 1138P A prospective study of patients with immune checkpoint inhibitor-induced hepatitis: Management outcome and association with liver injury subtype, immune infiltration, and clinical parameters.
المؤلفون: Holmstroem, R.B.1 (AUTHOR), Teisner, A.S.2 (AUTHOR), Sweep, M.3 (AUTHOR), Noringriis, I.M.1 (AUTHOR), Khan, S.1 (AUTHOR), Aagaard, N.K.4 (AUTHOR), Nissen Bjerring, P.5 (AUTHOR), Jurlander, R.S.1 (AUTHOR), Jörn, J.E.1 (AUTHOR), Monberg, T.J.1 (AUTHOR), Vestergaard, C.D.1 (AUTHOR), Stoltenborg Granhøj, J.1 (AUTHOR), Stenbøg, P.2 (AUTHOR), Bol, K.3 (AUTHOR), Jönsson, G.6 (AUTHOR), Ellebaek, E.1 (AUTHOR), Svane, I.M.1 (AUTHOR)
المصدر: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS746-S747. 2p.
مصطلحات موضوعية: *IMMUNE checkpoint proteins, *LIVER injuries, *LONGITUDINAL method, *HEPATITIS
قاعدة البيانات: Academic Search Index
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2024.08.2141